Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 15485-80-0 | MDL No. : | MFCD01546432 |
Formula : | C15H9NO5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CEESSYSSRMOMDE-UHFFFAOYSA-N |
M.W : | 283.24 | Pubchem ID : | 7454026 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 16 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 78.77 |
TPSA : | 96.26 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.15 cm/s |
Log Po/w (iLOGP) : | 1.88 |
Log Po/w (XLOGP3) : | 2.65 |
Log Po/w (WLOGP) : | 3.07 |
Log Po/w (MLOGP) : | 0.65 |
Log Po/w (SILICOS-IT) : | 1.3 |
Consensus Log Po/w : | 1.91 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.7 |
Solubility : | 0.0569 mg/ml ; 0.000201 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.32 |
Solubility : | 0.0135 mg/ml ; 0.0000476 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.93 |
Solubility : | 0.00333 mg/ml ; 0.0000117 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.76 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
16.4% | Stage #1: With pyridine; boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 75℃; for 1.5 h; Stage #2: With phosphorus pentachloride In N,N-dimethyl-formamide at 55℃; for 0.5 h; |
In the first reaction flask, resorcinol (0.72 g, 6.5 mmol), p-nitrophenylacetic acid (1.0 g, 6.0 mmol), BF 3 / Et 2 O (10 mL) was added and stirred at 75 ° C Reaction for 90 min. The reaction was completed, cooled to below 10 ° C, and DMF (10 mL) was added slowly with stirring. (0.72g6.5mmol)(1.0g6.0mmol)BF 3 /Et 2 O(10mL)75°C90min 10°CDMF(10mL) In a second reaction flask, DMF (20 mL) was added, cooled to below 10 ° C, and PCl 5 (2.0 g, 9 mmol) was added portionwise and stirred at 55 ° C for 30 min. The reaction was completed, cooled to below 10 ° C, slowly added to the first reaction flask, room temperature reaction 1h. After completion of the reaction, the reaction solution was poured into hot dilute hydrochloric acid (0.1 N) with stirring, and the solid was precipitated, suction filtered, washed with water and dried. The crude product was recrystallized from methanol to give 0.36 g of product, yield 16.4percent. MS (ESI): m / z = 284 [M + H] & lt; + & gt ;. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21% | Stage #1: at 85℃; for 1.5 h; Stage #2: at 10 - 25℃; for 2 h; |
4.1.2 7-Hydroxy-3-(4-nitrophenyl)-4H-benzopyran-4-one (9) A mixture of 4-nitrophenylacetic acid (7; 1.0 g, 6.0 mmol), resorcinol (8; 0.72 g, 6.5 mmol) and BF3/Et2O (10 ml) was heated at 85 °C for 1.5 h with stirring, then cooled down to 10 °C and 10 ml DMF was added slowly. In another flask, 10 ml DMF was added and cooled to 10 °C, PCl5 (2.0 g, 9 mmol) was added in batches, afterwards the mixture was heated to 55 °C and stirred for 0.5 h, after that cooled to 10 °C. Then the mixture was added by droplet into the first flask and stirred at 25 °C for 2 h. Then the reaction mixture was poured into heated dilute hydrochloric acid (0.5 mol/L). The product was filtered, and purified by recrystallization from methanol to yield 9 (0.36 g, 1.26 mmol, 21percent) as a white solid. 1H NMR (DMSO, 300 MHz): δ 8.48 (s, 1H, H-2), 8.28 (2H, J = 8.8 Hz, H-3', H-5'), 8.07 (d, 1H, J = 8.8 Hz, H-5), 7.96 (d, 2H, J = 8. 8 Hz, H-2', H-6'), 7.05 (dd, 1H, J = 8.8, 2.4 Hz, H-6), 6.97 (d, 1H, J = 2.4 Hz, H-8); MS (ESI): m/z = 282 [M-H]-. |
[ 1450-76-6 ]
1-(2-Hydroxy-5-nitrophenyl)ethanone
Similarity: 0.86
[ 134612-80-9 ]
(4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone
Similarity: 0.85
[ 55805-95-3 ]
1-(2-Hydroxy-5-nitrophenyl)propan-1-one
Similarity: 0.80
[ 64611-67-2 ]
2-Hydroxy-1-(4-nitrophenyl)ethanone
Similarity: 0.69
[ 1016-58-6 ]
(4,5-Dimethoxy-2-nitrophenyl)methanol
Similarity: 0.69
[ 5804-49-9 ]
(2-Methoxy-5-nitrophenyl)methanol
Similarity: 0.68
[ 175281-76-2 ]
4-(4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoic acid
Similarity: 0.66
[ 4996-22-9 ]
2,2-Dihydroxy-1-(4-nitrophenyl)ethanone
Similarity: 0.66
[ 1450-76-6 ]
1-(2-Hydroxy-5-nitrophenyl)ethanone
Similarity: 0.86
[ 134612-80-9 ]
(4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone
Similarity: 0.85
[ 55805-95-3 ]
1-(2-Hydroxy-5-nitrophenyl)propan-1-one
Similarity: 0.80
[ 113352-66-2 ]
1-(4-Methoxy-2-nitrophenyl)propan-2-one
Similarity: 0.79
[ 1450-76-6 ]
1-(2-Hydroxy-5-nitrophenyl)ethanone
Similarity: 0.86
[ 134612-80-9 ]
(4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone
Similarity: 0.85
[ 1890299-47-4 ]
Potassium 7-nitro-2-oxo-2H-chromene-3-carboxylate
Similarity: 0.71